P213 Patients with IPF demonstrate hyper-responsiveness and hypersensitivity to a range of tussive agents in a different pattern to R/UCC patients

Abstract

BackgroundCough in idiopathic pulmonary fibrosis (IPF) is an unmet clinical need. Though previous work has demonstrated heightened sensitivity to the TRPV1 agonist capsaicin using traditional cough challenge methodology, little is...